Chrome Extension
WeChat Mini Program
Use on ChatGLM

Phase I-II Open Label Multicenter Study of PD0332991 in BRAFV600mut Metastatic Melanoma Patients Harboring CDKN2A Loss and RB1 Expression and Treated with Vemurafenib.

Journal of Clinical Oncology(2019)

Cited 3|Views59
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined